Friday, July 10, 2026

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
443
Patents
706
Clinical program

Idefirix 11 mg powder for concentrate for solution for infusion

Phase 2 · small molecule · neuromyelitis optica spectrum disorder, devic disease

Idefirix 11 mg powder for concentrate for solution for infusion for neuromyelitis optica spectrum disorder, devic disease is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

← All Disc Medicine projects Phase 2 small molecule active

Internal code NL80681.078.22

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Disc Medicine
Phase
Phase 2
Modality
small_molecule
Indication
neuromyelitis optica spectrum disorder, devic disease
Status
active
Trials
1